Targeting intrinsically disordered nuclear protein 1 (NUPR1) with single-domain antibodies alleviates triple-negative breast cancer (TNBC) progression in vivoTianzhuo Wang, Zhenyi Ma|Cell Death and Disease|2025Cited by 0